Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease
Yan-Ci Zhao, Guojun Zhao, Ze Chen, et al.
Hypertension (2019) Vol. 75, Iss. 2, pp. 275-284
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

The utility of radiological imaging in nonalcoholic fatty liver disease
Sherif Saadeh, Zobair M. Younossi, Erick M. Remer, et al.
Gastroenterology (2002) Vol. 123, Iss. 3, pp. 745-750
Closed Access | Times Cited: 2058
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1137
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Ariel E. Feldstein, Ali Canbay, Paul Angulo, et al.
Gastroenterology (2003) Vol. 125, Iss. 2, pp. 437-443
Open Access | Times Cited: 1038
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 935
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors
Emir Muzurović, Carol Chiung‐Hui Peng, Matthew J. Belanger, et al.
Hypertension (2022) Vol. 79, Iss. 7, pp. 1319-1326
Closed Access | Times Cited: 85
Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults
Hongye Peng, Liang Pan, Simiao Ran, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 51
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu, Peng Zhang, Junjie Zhou, et al.
Cell Metabolism (2020) Vol. 31, Iss. 4, pp. 726-740.e8
Open Access | Times Cited: 81
Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia
Ze Chen, Jiayi Liu, Feng Zhou, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1747-1765
Open Access | Times Cited: 76
Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3
Peng Gao, Mei You, Li Li, et al.
Circulation (2022) Vol. 145, Iss. 5, pp. 375-391
Open Access | Times Cited: 65
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Paola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 7
Open Access | Times Cited: 56
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group
Stuart McPherson, Matthew J. Armstrong, Jeremy Cobbold, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 8, pp. 755-769
Open Access | Times Cited: 52
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
Cheng Han Ng, Zhen Yu Wong, Nicholas Chew, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 44
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4556-4556
Open Access | Times Cited: 43
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 40
Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease
Gashaw Hassen, Abhishek Singh, Gizeshwork Belete, et al.
Cureus (2022)
Open Access | Times Cited: 40
High Remnant Cholesterol Level Potentiates the Development of Hypertension
Mingming Chen, Xuewei Huang, Chengsheng Xu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Olufunto O. Badmus, Terry D. Hinds, David E. Stec
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 151-162
Open Access | Times Cited: 39
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Fernando Bril, Arun J. Sanyal, Kenneth Cusi
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 187-210
Closed Access | Times Cited: 35
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
Preeti Dinesh Virwani, Gordon Qian, Matthew S.S. Hsu, et al.
Hypertension (2023) Vol. 80, Iss. 6, pp. 1331-1342
Open Access | Times Cited: 27
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction–Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study
Ki‐Chul Sung, Tae Kyung Yoo, Mi Yeon Lee, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 3, pp. 482-491
Open Access | Times Cited: 23
Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease
Nicholas R. Powell, Tiebing Liang, Joseph Ipe, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Oxidative balance score is inversely associated with the incidence of non-alcoholic fatty liver disease
A‐Ra Cho, Yu‐Jin Kwon, Jun‐Hyuk Lee
Clinical Nutrition (2023) Vol. 42, Iss. 8, pp. 1292-1300
Closed Access | Times Cited: 23
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Daniel Clayton‐Chubb, William Kemp, Ammar Majeed, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 687-687
Open Access | Times Cited: 22
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top